ALLI SKEEHAN: Open Payments
NPI 1821789223 · SIERRA VISTA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 26 payments from 12 companies in 2025. Trend: 2023 $786 · 2024 $1,160 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $284 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $82 |
| Amgen Inc. | 3 | $58 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: BREZTRI, ZENPEP, AIRSUPRA, XIFAXAN, EVENITY, GARDASIL 9, REXULTI, VRAYLAR.
Industry payments across AZ — which companies pay providers there.
